RI-Activated Mast Cells
Department of Biochemistry, Hebrew University Hadassah Medical School, P.O. Box 12272, Jerusalem 91120, Israel
Received 24 February 2005/ Returned for modification 7 April 2005/ Accepted 18 July 2005
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Among the aaRSs that posses multiple functions are TyrRS and TrpRS, which can also act as cytokines. Protease cleavage of TyrRS creates two distinct cytokines that induce angiogenesis and leukocyte recruitment (42), whereas alternative splicing of TrpRS transcripts produces antiangiogenic factor (29, 43). In our recent work, we provided evidence for the involvement of aaRS in transcriptional regulation by demonstrating the involvement of lysyl tRNA synthetase (LysRS) in the regulation of microphthalmia transcription factor (MITF) transcriptional activity (18). LysRS, as a part of the multiprotein complex with MITF and Hint, synthesizes Ap4A in close proximity to Hint. Ap4A binds to Hint, the suppressor of MITF's transcriptional activity, and this leads to the dissociation of Hint from MITF, thus allowing MITF to transactivate its target genes upon specific trigger.
LysRS is also known to synthesize Ap4A in mammals in a zinc-dependent chemical reaction (7, 13). Ap4A is a diadenosine polyphosphate, a naturally occurring group of molecules in which two adenosines are joined by three to six phosphate groups. These molecules are structural analogues of NTPs that are highly charged and have affinity to proteins (5). One such protein is Hint, which dissociates from MITF transcription factor on binding to an Ap4A molecule (18). An additional intracellular function proposed for Ap4A is a role in the induction of apoptosis, based on experiments showing that administration of Ap4A to a variety of cell lines causes cellular apoptosis (40).
Other basic helix-loop-helix leucine zipper (bHLH-Zip) transcription factors that belong to the same family of proteins as MITF are USF1 and USF2. These two transcription factors, unlike MITF, are ubiquitously expressed in eukaryotic cells where they are involved in a broad spectrum of biological activities (19, 28). For instance, both proteins are essential for embryonic development, since an embryonic lethal phenotype was observed with the double-null mouse mutants (34). Furthermore, USF2-null mice show a more severe phenotype than USF1-null mice, with severe growth defects, abnormalities in fertility, mammary gland malfunction, and an impaired transcriptional response to glucose in liver (12, 34, 39). Previously, we provided evidence for a direct connection between cell surface receptor-mediated USF2 nuclear translocation and cell viability (9). Another study demonstrated the involvement of USF in cell division as a negative regulator of cell proliferation by antagonizing the transforming function of Myc (24).
One of the ways to elucidate the precise functional regulation of USF2 activity could be performed by investigating its possible association with other molecules. A candidate protein for such an association with USF2 is Hint, which negatively regulates the transcriptional activity of MITF (18, 31). This ubiquitously expressed protein was recently determined to be a tumor suppressor gene (37) and is a member of the histidine triad (HIT) protein family, indicated by a conserved HIT motif sequence (23). This protein and other members of the HIT family are extremely conserved, ranging from prokaryotes to humans. In vitro assays show that HIT proteins have catalytic activity and are able to bind nucleotidyl substrates (6, 23), and Hint was shown to specifically interact with Ap4A by BIAcore analysis (18). Furthermore, the physical and genetic association of Hint with a part of the basal transcription factor TFIIH is conserved in yeast and humans, showing the functional significance of Hint (17). The possible interaction of Hint with USF2 would provide further insight into the molecular mechanisms underlying USF2 transcriptional activity.
In the present study, we show that USF2 is associated with Hint, which suppresses USF2 transcriptional activity. Furthermore, LysRS forms a multiprotein complex with USF2 and Hint and produces Ap4A, which dissociates Hint from USF2 and thus allows the transcription of USF2-responsive genes. This molecular mechanism of USF2 transcriptional activity closely follows the molecular mechanism of MITF activity. Here, we show the broadening of LysRS's function as a positive regulator of transcription factors via the synthesis of Ap4A in eukaryotic cells. This is a novel topic, which has implications for our understanding of a variety of cellular functions.
| MATERIALS AND METHODS |
|---|
|
|
|---|
) were kindly provided by M. Mirande (2). The Lys-101 CHO cell line (1) and Lys-101 stably transformed CHO cells with pSG/CKRS and pSG/CKRS
(2) were maintained in at 34°C in RPMI 1640 medium supplemented with 8 mM L-glutamine, 2 mM nonessential amino acids, 100 units/ml penicillin, and 100 µg/ml streptomycin (Life Technologies, Inc.). Plasmid construction. Normal mouse Hint (381 bp) was inserted into pGEX3X vector (Amersham Biosciences, Uppsala, Sweden) and pcDNA 3.1. Mouse MITF (1,129 bp) was inserted into the pGEX-4T-3 vector (Stratagene, La Jolla, Calif.). Fidelity of the constructs was verified by direct sequencing. The luciferase reporter plasmid pSP72, containing the MITF binding region of the promoter and the first exon of the mMCP-6 gene (191 to + 26), as well as a construct with a deleted MITF binding site (151 to + 26), was generously provided by Y. Kitamura, Osaka, Japan. pCMV-USF2 and its reporter gene pU3ML, containing three USF2-responsive elements (E-box) (14), were kindly provided by M. Sawadogo (The University of Texas, Houston, Tex.). STAT3-C and the M67 pTATA tk-Luc reporter gene were kindly provided by J. E. Darnell (The Rockefeller University, New York, N.Y.). The PKA catalytic subunit beta (PKA-Cß) luciferase reporter gene with a human promoter containing c-myc-responsive elements was kindly provided by R. Dalla-Favera (Columbia University, New York, N.Y.) (45).
In vitro GST pulldown assay. Glutathione S-transferase (GST)-Hint fusion protein was expressed in protease-deficient Escherichia coli strain BL-21 and purified on glutathione-Sepharose beads (Amersham Biosciences). Pulldown assays were performed as described previously (21). The integrity and quantity of GST fusion proteins were confirmed by Gelcode Bluestain reagent (Pierce Biotechnology, Inc., Rockford, Ill.), and autoradiography detected the amount of retained radiolabeled 35S-labeled USF2.
Immunoprecipitation. The immunoprecipitation of the specific proteins from RBL cells was carried out as previously described (21). The antibodies that were used for immunoprecipitation were anti-mouse USF2, anti-mouse MITF, anti-mouse Hint, and anti-human LysRS, which was kindly provided by L. Kleiman (Lady Davis Institute for Medical Research, Montreal, Canada).
Nucleotide assay. This assay detects the relative amount of Ap4A present in extracts of mammalian cells. For each determination, cells from one well of a six-well plate were grown to about 80% confluence. The cell layer was washed with warm serum-free medium and was lysed with trichloroacetic acid. Extraction and measurement by luminometry of the nucleotides were performed as described previously (27).
PCR amplification. Primers were used to amplify USF2 from mouse cDNA. The primers were designed by including a T7 promoter sequence and a ribosome binding site into the 5' primers. The primers for USF2 were a sense 5' (5'-CTAATACGACTCACTATAGGGAAGGAGATATACATATGGACATGCTG GACCCGGGTCTGGAT-3') and anti-sense 3' (5'-TTACTGCCGGGTACTCTCGCCCAC-3').
Real-time quantitative PCR.
MITF-responsive genes were measured by using real-time quantitative PCR. Total RNA was extracted from RBL cells, and mRNA levels of various genes were quantified by SYBR-green incorporation (SYBR Green PCR Master Mix; Applied Biosystems, Foster City, Calif.). SYBR-green incorporation to double-strand DNA permits the direct detection of PCR product after each amplification cycle (ABI Prism 7000 sequence detection system; Applied Biosystems). The specificity of the amplification was controlled by electrophoresis. The genes whose mRNA levels were quantified by real-time PCR were Rat CXCR4, Fc
RI, TGF-ß2, and actin genes.
Transient cotransfection and luciferase assay. NIH 3T3 cells (2 x 105) were cotransfected by Transfast reagent (Promega Biosciences, San Luis Obispo, Calif.) with 0.5 µg of reporter pU3ML containing three E-boxes, 0.1 µg of pCMV-USF2, and 0.5 µg pcDNA-Hint and pcDNA alone as a nonspecific control. The cells were incubated in 24-well plates for 48 h. CHO cells (2 x 105) were transfected by Transfast reagent with 0.1 µg of various reporter genes: pSP72 for MITF, pU3ML for USF2, and PKA-Cß for c-Myc. For STAT3, both the promoter M67 and constitutively active STAT3 (designated STAT3-C) were cotransfected. The luciferase activity was normalized to the total protein concentration. The ratio was expressed as relative luciferase activity.
| RESULTS |
|---|
|
|
|---|
|
The physiological significance of the USF2 and Hint association was first determined by checking whether the signal from high-affinity immunoglobulin E (IgE) receptor Fc
RI led to any change in the protein-protein association, as was shown with MITF (18). Stimulation of RBL cells with IgE and 2,4-dinitrophenol (DNP) for 1 h dissociated Hint from USF2 (Fig. 2A). Both USF2 and Hint protein levels were unchanged with the stimulation of IgE and DNP (Fig. 2B). Next, the effect of Hint on the transcriptional activity of USF2 was assayed by using a luciferase reporter gene. Plasmids containing USF2, Hint, and the luciferase reporter gene with the promoter of USF2-responsive elements were cotransfected to NIH 3T3 cells. Increasing amounts of Hint showed a decrease in luciferase activity, suggesting that Hint serves as a suppressor of USF2 transcriptional activity (Fig. 2C).
|
|
|
RI, adenomatous polyposis coli (APC) tumor suppressor, thrombospondin 1 (TSP-1), telomerase catalytic subunit (TERT), protein tyrosine phosphatase 1 (SHP), and transforming growth factor ß2 (TGF-ß2)were tested. Of these target genes, only TERT, SHP, and TGF-ß2 genes showed significant increase in their transcript levels upon 6 to 10 h of immunological triggering (Fig. 5A). The most profound elevation in the transcript level was observed with the TGF-ß2 gene. The TGF-ß2 gene is a specific target gene of USF2 (16), and it is involved in a broad range of cellular events such as cell growth, differentiation, and tissue morphogenesis (15, 26, 32); it is also considered a potent immunosuppressive cytokine. Next, the transcript levels of the above USF2 target genes in Ap4A-administered RBL cells were determined. The cells were incubated at 37°C for 12 h prior to RNA extraction. The introduction of Ap4A specifically increased the transcript level of the TGF-ß2, TERT, and SHP genes. It should be noted that the transcript level of the TSP-1 gene was elevated due to the introduction of Ap4A, despite its nonsignificant elevation in the transcript level in immunologically activated cells (Fig. 5B). This indicates that immunologically induced USF2 activity on the transcription of TGF-ß2, TERT, and SHP genes was mediated by Ap4A and that Ap4A alone might induce the TSP-1 gene. It is important to note that AMP, a by-product of Ap4A degradation, did not show any significant effect on the transcript levels of USF2-dependent genes, including TGF-ß2. It is interesting to note that other TGF-ß genes were not affected.
|
|
Next, the transcriptional activity of USF2 and MITF in the cells that overexpress LysRS was determined by transfecting them with the luciferase reporter gene consisting of either USF2- or MITF-responsive elements. Lys-101 CHO cells that overexpress full-length LysRS significantly showed higher transcriptional activity of both USF2 and MITF (Fig. 6B). The transcriptional activity of other transcription factors such as c-Myc and STAT3 was tested and showed no change in transcriptional activity in Lys-101 CHO cells that overexpressed the truncated LysRS, compared to Lys-101 CHO cells that overexpressed full-length LysRS. Western blot analysis of these CHO cell lysates verified the presence of MITF, USF2, c-Myc, and STAT-3 (data not shown).
To determine whether there was any differences in the USF/Hint or MITF/Hint protein complexes, Lys-101 CHO cells stably transformed with pSG/CKRS and pSG/CKRS^N cells were subjected to coimmunoprecipitation analysis. Lys-101 CHO cells that overexpressed LysRS, thus having higher Ap4A levels, showed a decrease in the USF2/Hint and MITF/Hint protein complexes (Fig. 6C). This set of experiments clearly showed that LysRS was an inducer of USF2 (as well as MITF) transcriptional activity via the synthesis of Ap4A. As we have previously shown with MITF, it can be logically postulated that the accumulated Ap4A binds to Hint (18) and liberates USF2 to transactivate the target genes of USF2.
| DISCUSSION |
|---|
|
|
|---|
In contrast to MITF, which is expressed in specific cell types, USF2 is a ubiquitously expressed transcription factor, which has been shown to regulate many genes in various cell types by binding to the E-box element in the promoter. For instance, in mesangial cells USF2 specifically mediates the glucose-induced TSP-1 and TSP-1-dependent TGF-ß activity (44). In nontumorigenic mammary epithelial cells, USF2 regulates the transcript levels of insulin-like growth factor 2 receptor, but interestingly it loses its ability to transactivate insulin-like growth factor 2 receptor in breast cancer cells (38). Furthermore, extensive studies were carried out on the regulation of USF2 expression in interleukin 3 activated mast cells, where an induction of USF2 protein synthesis was observed via increased translational efficiency (22, 48). We previously utilized cell permeable peptides as inhibitors of the activity of the USF2 proteins, to demonstrate its possible role in mast cell survival (9). Here, we demonstrate for the first time the association of LysRS and Ap4A with the molecular mechanism that regulates USF2 activity. Since USF2 plays a significant role in variety of cellular functions, it suggests that perhaps LysRS and Ap4A are involved in general regulation of transcriptional activity.
It is interesting to note that the induction of USF2 transcriptional activity via Ap4A in a mast cell line affects only certain USF2 target genes such as TGF-ß2. Thus, it could be assumed that Ap4A mediates the regulation of a limited number of USF2 target genes. This is despite the fact that USF2 is broadly expressed in many cell types, has multiple target genes, and is involved in variety of physiological functions.
TGF-ß2 belongs to the TGF protein family, which is one of the seven major families of growth factors that control numerous intracellular processes. This growth factor controls the differentiation, proliferation, and activation states of lymphocytes, macrophages, and dendritic cells and thus plays a critical role in the mechanism of tolerance autoimmunity and in anti-inflammatory processes. Furthermore, TGF-ß is an immunoregulatory molecule, which serves initially as an immune response inducer and then acts as an immunosuppressive agent (20). Additionally, TGF-ß knockout mice develop inflammation in various tissues (33). Therefore, it is intriguing to observe that among the USF2 target genes, only TGF-ß2 shows a significant response to activated mast cells and ectopically introduced Ap4A, a positive regulator of USF2 transcription factor that is elevated upon immunological triggering in mast cells.
It is interesting to note that only specific USF2 target genes are affected (TGF-ß2, SHP, TERT, and TSP-1 genes) in a manner similar in both IgE-Ag-triggered and Ap4A-administered mast cells. Mast cells express numerous cell surface molecules and undergo a wide variety of activations. Thus, we assume that the activation of these specific USF2 target genes is specific to IgE-Ag stimulation via Ap4A, whereas other USF2 target genes that were not affected by IgE-Ag and Ap4A are affected by other stimulation and signal transduction. Further studies are needed to determine the specific signal transduction and pathways, which lead to Ap4A synthesis and its role in the USF2 transcriptional activity.
As mentioned above, the TSP-1-dependent TGF-ß activity in mesangial cells (44) might be explained by the fact that both these genes are USF2-responsive genes and are elevated upon Ap4A administration, as was shown in the present study. Thus, it is possible that in mesangial cells under specific stimulus, USF2 transcriptional activity increases via Ap4A and thus activates the TSP-1 and TGF-ß2 genes. It is interesting to note that in both immunologically triggered and Ap4A-administered mast cells, the increase in transcription levels of the TGF-ß2 gene is higher than in the TSP-1 gene (Fig. 5). This observation strengthens the possibility that this unique molecular mechanism plays a more general role in different cell types.
It can be seen that Ap3A, a molecule closely related to Ap4A, has a similar effect on the USF2/Hint protein complex (Fig. 3A) and on USF2-mediated TGF-ß2 transcription (Fig. 5B). We have previously observed that exogenously introduced Ap3A to mast cells caused elevation of a specific MITF target gene (c-kit) (18). Furthermore, it was reported that LysRS can synthesize Ap3A when the level of ADP is higher than that of ATP, despite the fact that Ap4A synthesis is the more predominant reaction (4). The effects of Ap3A and Ap4A are controversial in physiological and cellular functions. Some studies show that Ap3A and Ap4A have similar antiapoptotic effects on neutrophils when administered together with granulocyte-macrophage colony-stimulating factor (10). Other studies demonstrate an elevation of Ap3A levels in differentiating HL60 cells, compared to an elevation of Ap4A levels in apoptotic HL60 cells (41). Therefore, further studies are required to evaluate the difference in the roles, if any, played by Ap3A and Ap4A in mast cell signaling and in other mammalian cells.
This study and our previous study (18) both demonstrate that immunological stimulation of RBL leads to elevated levels of Ap4A by LysRS, which is in complex with either USF2 or MITF, enhancing the transcriptional activity of USF2 and MITF. LysRS is involved in protein synthesis; thus, one of the challenging questions raised is what might be the possible mechanism leading to this alternate function of LysRS. In vitro studies show that phosphorylation of aaRS does not effect the aminoacylation reaction but increases up to sixfold in Ap4A production (8). It is possible that phosphorylation of LysRS leads to its association with either USF2 or MITF. In addition, it will be interesting to determine the fraction of LysRS that is bound to either USF2 or MITF. Further studies are needed to understand the mechanism of this receptor induced LysRS activation.
The two bHLH-zip transcription factors, USF2 and MITF, which are activated in immunologically triggered RBL cells, are regulated by an unusual regulatory mechanism. These two transcription factors are suppressed in resting RBL cells by Hint, which prevents them from trans-activating their responsive genes. Interestingly, LysRS, when it is associated with USF2 and MITF, acquires an unconventional function of synthesizing Ap4A in immunologically triggered RBL cells. The local accumulation of Ap4A leads to its binding to Hint, possibly causing conformational changes, and thus dissociating the transcription factors USF2 and MITF from their inhibitor (Fig. 7). Thus, deciphering the involvement of Ap4A in USF2 transcriptional activity may provide new insights into the mechanisms by which transcription factors of the bHLH-zip family are regulated.
|
| ACKNOWLEDGMENTS |
|---|
This work was supported by the United States-Israel Binational Science Foundation (grant 2003009; E.R.), the Israeli Academy of Science (grant 144/04; E.R.), and the German-Israeli Foundation for Scientific Research and Development (grant I-726-10.2/2002; E.R.).
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Agou, F., S. Quevillon, P. Kerjan, M. T. Latreille, and M. Mirande. 1996. Functional replacement of hamster lysyl-tRNA synthetase by the yeast enzyme requires cognate amino acid sequences for proper tRNA recognition. Biochemistry 35:15322-15331.[CrossRef][Medline]
3. Berger, N. A., and E. S. Johnson. 1976. DNA synthesis in permeabilized mouse L cells. Biochim. Biophys. Acta 425:1-17.[Medline]
4. Blanquet, S., P. Plateau, and A. Brevet. 1983. The role of zinc in 5',5'-diadenosine tetraphosphate production by aminoacyl-transfer RNA synthetases. Mol. Cell. Biochem. 52:3-11.[CrossRef][Medline]
5. Brenner, C., H. Cadiou, H. L. Vieira, N. Zamzami, I. Marzo, Z. Xie, B. Leber, D. Andrews, H. Duclohier, J. C. Reed, and G. Kroemer. 2000. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 19:329-336.[CrossRef][Medline]
6. Brenner, C., P. Garrison, J. Gilmour, D. Peisach, D. Ringe, G. A. Petsko, and J. M. Lowenstein. 1997. Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins. Nat. Struct. Biol. 4:231-238.[CrossRef][Medline]
7. Brevet, A., P. Plateau, B. Cirakoglu, J. P. Pailliez, and S. Blanquet. 1982. Zinc-dependent synthesis of 5',5'-diadenosine tetraphosphate by sheep liver lysyl- and phenylalanyl-tRNA synthetases. J. Biol. Chem. 257:14613-14615.
8. Dang, C. V., and J. A. Traugh. 1989. Phosphorylation of threonyl- and seryl-tRNA synthetase by cAMP-dependent protein kinase. A possible role in the regulation of P1, P4-bis(5'-adenosyl)-tetraphosphate (Ap4A) synthesis. J. Biol. Chem. 264:5861-5865.
9. Frenkel, S., G. Kay, H. Nechushtan, and E. Razin. 1998. Nuclear translocation of upstream stimulating factor 2 (USF2) in activated mast cells: a possible role in their survival. J. Immunol. 161:2881-2887.
10. Gasmi, L., A. G. McLennan, and S. W. Edwards. 1996. The diadenosine polyphosphates Ap3A and Ap4A and adenosine triphosphate interact with granulocyte-macrophage colony-stimulating factor to delay neutrophil apoptosis: implications for neutrophil:platelet interactions during inflammation. Blood 87:3442-3449.
11. Gregor, P. D., M. Sawadogo, and R. G. Roeder. 1990. The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev. 4:1730-1740.
12. Hadsell, D. L., S. Bonnette, J. George, D. Torres, Y. Klementidis, S. Gao, P. M. Haney, J. Summy-Long, M. S. Soloff, A. F. Parlow, M. Sirito, and M. Sawadogo. 2003. Diminished milk synthesis in upstream stimulatory factor 2 null mice is associated with decreased circulating oxytocin and decreased mammary gland expression of eukaryotic initiation factors 4E and 4G. Mol. Endocrinol. 17:2251-2267.
13. Hilderman, R. H., and B. J. Ortwerth. 1987. A preferential role for lysyl-tRNA4 in the synthesis of diadenosine 5',5'''-P1,P4-tetraphosphate by an arginyl-tRNA synthetase-lysyl-tRNA synthetase complex from rat liver. Biochemistry 26:1586-1591.[CrossRef][Medline]
14. Ismail, P. M., T. Lu, and M. Sawadogo. 1999. Loss of USF transcriptional activity in breast cancer cell lines. Oncogene 18:5582-5591.[CrossRef][Medline]
15. Kelly, D. L., and A. Rizzino. 1999. Growth regulatory factors and carcinogenesis: the roles played by transforming growth factor beta, its receptors and signaling pathways. Anticancer Res. 19:4791-4807.[Medline]
16. Kingsley-Kallesen, M., T. A. Luster, and A. Rizzino. 2001. Transcriptional regulation of the transforming growth factor-ß2 gene in glioblastoma cells. In Vitro Cell. Dev. Biol. Anim. 37:684-690.[CrossRef][Medline]
17. Korsisaari, N., and T. P. Makela. 2000. Interactions of Cdk7 and Kin28 with Hint/PKCI-1 and Hnt1 histidine triad proteins. J. Biol. Chem. 275:34837-34840.
18. Lee, Y. N., H. Nechushtan, N. Figov, and E. Razin. 2004. The function of lysyl-tRNA synthetase and Ap4A as signaling regulators of MITF activity in F
RI-activated mast cells. Immunity 20:145-151.[CrossRef][Medline]
19. Lemaitre, J. M., R. S. Buckle, and M. Mechali. 1996. c-Myc in the control of cell proliferation and embryonic development. Adv. Cancer Res. 70:95-144.[Medline]
20. Letterio, J. J., and A. B. Roberts. 1996. Transforming growth factor-ß1-deficient mice: identification of isoform-specific activities in vivo. J. Leukoc. Biol. 59:769-774.[Abstract]
21. Levy, C., H. Nechushtan, and E. Razin. 2002. A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor. J. Biol. Chem. 277:1962-1966.
22. Lewin, I., J. Jacob-Hirsch, Z. C. Zang, V. Kupershtein, Z. Szallasi, J. Rivera, and E. Razin. 1996. Aggregation of the Fc
RI in mast cells induces the synthesis of Fos-interacting protein and increases its DNA binding-activity: the dependence on protein kinase C-ß. J. Biol. Chem. 271:1514-1519.
23. Lima, C. D., M. G. Klein, and W. A. Hendrickson. 1997. Structure-based analysis of catalysis and substrate definition in the HIT protein family. Science 278:286-290.
24. Luo, X., and M. Sawadogo. 1996. Antiproliferative properties of the USF family of helix-loop-helix transcription factors. Proc. Natl. Acad. Sci. USA 93:1308-1313.
25. Martinis, S. A., P. Plateau, J. Cavarelli, and C. Florentz. 1999. Aminoacyl-tRNA synthetases: a family of expanding functions. Mittelwihr, France, October 10-15, 1999. EMBO J. 18:4591-4596.[CrossRef][Medline]
26. Massague, J. 2000. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1:169-178.[CrossRef][Medline]
27. Murphy, G. A., D. Halliday, and A. G. McLennan. 2000. The Fhit tumor suppressor protein regulates the intracellular concentration of diadenosine triphosphate but not diadenosine tetraphosphate. Cancer Res. 60:2342-2344.
28. Nechushtan, H., and E. Razin. 1998. Deciphering the early-response transcription factor networks in mast cells. Immunol. Today 19:441-444.[CrossRef][Medline]
29. Otani, A., B. M. Slike, M. I. Dorrell, J. Hood, K. Kinder, K. L. Ewalt, D. Cheresh, P. Schimmel, and M. Friedlander. 2002. A fragment of human TrpRS as a potent antagonist of ocular angiogenesis. Proc. Natl. Acad. Sci. USA 99:178-183.
30. Randerath, K., C. M. Janeway, M. L. Stephenson, and P. C. Zamecnik. 1966. Isolation and characterization of dinucleoside tetra- and tri-phosphates formed in the presence of lysyl-sRNA synthetase. Biochem. Biophys. Res. Commun. 24:98-105.[CrossRef][Medline]
31. Razin, E., Z. C. Zhang, H. Nechushtan, S. Frenkel, Y. N. Lee, R. Arudchandran, and J. Rivera. 1999. Suppression of microphthalmia transcriptional activity by its association with protein kinase C-interacting protein 1 in mast cells. J. Biol. Chem. 274:34272-34276.
32. Roberts, A. B., and M. B. Sporn. 1993. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 8:1-9.[Medline]
33. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-ß1 gene results in multifocal inflammatory disease. Nature 359:693-699.[CrossRef][Medline]
34. Sirito, M., Q. Lin, J. M. Deng, R. R. Behringer, and M. Sawadogo. 1998. Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice. Proc. Natl. Acad. Sci. USA 95:3758-3763.
35. Sirito, M., Q. Lin, T. Maity, and M. Sawadogo. 1994. Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res. 22:427-433.
36. Sirito, M., S. Walker, Q. Lin, M. T. Koslowski, W. H. Klein, and M. Sawadogo. 1992. Member of the USF family of helix-loop-helix proteins bind DNA as homo- as well as heterodimers. Gene Expr. 2:231-240.[Medline]
37. Su, T., M. Suzui, L. Wang, C. S. Lin, W. Q. Xing, and I. B. Weinstein. 2003. Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis. Proc. Natl. Acad. Sci. USA 100:7824-7829.
38. Szentirmay, M. N., H. X. Yang, S. A. Pawar, C. Vinson, and M. Sawadogo. 2003. The IGF2 receptor is a USF2-specific target in nontumorigenic mammary epithelial cells but not in breast cancer cells. J. Biol. Chem. 278:37231-37240.
39. Vallet, V. S., M. Casado, A. A. Henrion, D. Bucchini, M. Raymondjean, A. Kahn, and S. Vaulont. 1998. Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose. J. Biol. Chem. 273:20175-20179.
40. Vartanian, A., I. Alexandrov, I. Prudowski, A. McLennan, and L. Kisselev. 1999. Ap4A induces apoptosis in human cultured cells. FEBS Lett. 456:175-180.[CrossRef][Medline]
41. Vartanian, A., I. Prudovsky, H. Suzuki, I. Dal Pra, and L. Kisselev. 1997. Opposite effects of cell differentiation and apoptosis on Ap3A/Ap4A ratio in human cell cultures. FEBS Lett. 415:160-162.[CrossRef][Medline]
42. Wakasugi, K., and P. Schimmel. 1999. Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 284:147-151.
43. Wakasugi, K., B. M. Slike, J. Hood, A. Otani, K. L. Ewalt, M. Friedlander, D. A. Cheresh, and P. Schimmel. 2002. A human aminoacyl-tRNA synthetase as a regulator of angiogenesis. Proc. Natl. Acad. Sci. USA 99:173-177.
44. Wang, S., J. Skorczewski, X. Feng, L. Mei, and J. E. Murphy-Ullrich. 2004. Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-beta activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2. J. Biol. Chem. 279:34311-34322.
45. Wu, K. J., M. Mattioli, H. C. Morse III, and R. Dalla-Favera. 2002. c-MYC activates protein kinase A (PKA) by direct transcriptional activation of the PKA catalytic subunit beta (PKA-Cß) gene. Oncogene 21:7872-7882.[CrossRef][Medline]
46. Zamecnik, P. C. 1969. An historical account of protein synthesis, with current overtonesa personalized view. Cold Spring Harb. Symp. Quant. Biol. 34:1-16.[Medline]
47. Zamecnik, P. C., M. L. Stephenson, C. M. Janeway, and K. Randerath. 1966. Enzymatic synthesis of diadenosine tetraphosphate and diadenosine triphosphate with a purified lysyl-sRNA synthetase. Biochem. Biophys. Res. Commun. 24:91-97.[CrossRef][Medline]
48. Zhang, Z. C., H. Nechushtan, J. Jacob-Hirsch, D. Avni, O. Meyuhas, and E. Razin. 1998. Growth-dependent and PKC-mediated translational regulation of the upstream stimulating factor-2 (USF2) mRNA in hematopoietic cells. Oncogene 16:763-769.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|